Evidence map›Paper›PMID 33659267›Full record

ArticleFrontiers in nutrition2021

Design and Feasibility of a Randomized Controlled Pilot Trial to Reduce Exposure and Cognitive Risk Associated With Advanced Glycation End Products in Older Adults With Type 2 Diabetes.

Roni Lotan, Ithamar Ganmore, Abigail Livny, Shahar Shelly, Moran Zacharia, Jaime Uribarri, Paul Beisswenger, Weijing Cai, Michal Schnaider Beeri, Aron M Troen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Roni LotanThe Nutrition and Brain Health Laboratory, The Robert H. Smith Faculty of Agriculture Food and the Environment, The Institute of Biochemistry, Food and Nutrition Science, The Hebrew University of Jerusalem, Rehovot, Israel.
Ithamar GanmoreThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel.
Abigail LivnyThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel.
Shahar ShellyThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel.
Moran ZachariaThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel.
Jaime UribarriIcahn School of Medicine at Mount Sinai, New York, NY, United States.
Paul BeisswengerPreventAGE Healthcare, Lebanon, NH, United States.
Weijing CaiIcahn School of Medicine at Mount Sinai, New York, NY, United States.
Michal Schnaider BeeriThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel.
Aron M TroenThe Nutrition and Brain Health Laboratory, The Robert H. Smith Faculty of Agriculture Food and the Environment, The Institute of Biochemistry, Food and Nutrition Science, The Hebrew University of Jerusalem, Rehovot, Israel.
Hebrew University of Jerusalem · ILIcahn School of Medicine at Mount Sinai · USSheba Medical Center · ILTel Aviv University · ILMayo Clinic in Arizona · USPreventAGE Health Care (United States) · US

Funding

Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular diseaseR01AG061093 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SCHNAIDER BEERI, MICHAL · 2019 to 2024
$4.3M
NIA NIH HHS R01 AG061093
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced glycation end productsdietfeasibilitymild cognitive impairmentpilotrandomized controlled trialtype 2 diabetes

Identifiers

PMID33659267
PMCPMC7917071
OpenAlexW3131361580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.